Showing results (81-90 of 256) with videos related to
Sort By:
Pageof 26
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 8, 2019
Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylateEmily A Rosenthal, Pei-Shu Ho, Galen O Joe, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cellsJason E Foley, Jacopo Mariotti, Kaitlyn Ryan, et al.Archives of Physical Medicine and Rehabilitation|December 21, 2020
Rehabilitation Interventions in the Multidisciplinary Management of Patients With Sclerotic Graft-Versus-Host Disease of the Skin and FasciaPaula Molés-Poveda, Leora E Comis, Galen O Joe, et al.Journal of Clinical Immunology|July 19, 2012
Quantitative salivary proteomic differences in oral chronic graft-versus-host diseaseCarol W Bassim, Kiran S Ambatipudi, Jacqueline W Mays, et al.Transplantation and Cellular Therapy|March 7, 2025
Efficacy of Pomalidomide on Motor Performance and Functional Abilities in Patients with Steroid Refractory Chronic Graft Versus Host Disease: A Randomized Clinical StudyJessica J Jorgensen, Galen O Joe, Rafael Jiménez-Silva, et al.Blood|November 4, 2015
Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host diseaseJeanne Palmer, Xiaoyu Chai, Joseph Pidala, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHDDaniel Wolff, Armin Gerbitz, Francis Ayuk, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2004
Co-stimulated/Tc2 cells abrogate murine marrow graft rejectionAndreas A Erdmann, Unsu Jung, Jason E Foley, et al.American Journal of Hematology|March 30, 2005
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantationSteven Z Pavletic, Lynette M Smith, Michael R Bishop, et al.Frontiers in Immunology|August 2, 2021
Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort StudyEma Prenc, Drazen Pulanic, Maja Pucic-Bakovic, et al.Pageof 26